Use this URL to cite or link to this record in EThOS:
Title: Design, synthesis and biological evaluation of some novel phosphoramidate prodrugs
Author: Daverio, Felice
ISNI:       0000 0004 2749 2498
Awarding Body: Cardiff University
Current Institution: Cardiff University
Date of Award: 2006
Availability of Full Text:
Access from EThOS:
Access from Institution:
An introduction to the work presented within this thesis involves a brief overview of nucleosides, nucleotides and nucleic acids. Descriptions of the prodrug concept and pronucleotide approaches are also given. The work presented within this thesis describes the synthesis and biological evaluation of a number of phosphoramidate derivatives of some nucleoside analogues. This includes phosphoramidates of E-5-2-bromovinyl-2'-deoxyuridine BVdU, 2//3'-dideoxyadenosine ddA, 9-p-D-arabinofuranosyl-2-fluoroadenine F-Ara-A, fludarabine, and 2',2'-difluorodeoxycytidine Gemzar, gemcitabine. Extensive SAR studies of the anticancer lead thymectacin phenyl-methoxy-L-alaninyl-BVdU phosphoramidate revealed a significant enhancement of potency in vitro in colon and prostate cancer cell lines. A small series of phosphoramidates of the anticancer agents gemcitabine and fludarabine was synthesised and evaluated for their cytotoxic activities but not significant improvement in in vitro activity was observed. Finally, a series of phosphoramidate derivatives of 2',3'-dideoxyadenosine was synthesised and tested as inhibitors of endothelium-derived hyperpolarizing factor EDHF. This represents the first example of the application of phosphoramidate derivatives as non antiviral/anticancer agents.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available